Ignite Creation Date:
2024-05-06 @ 1:03 AM
Last Modification Date:
2024-10-26 @ 10:58 AM
Study NCT ID:
NCT01711099
Status:
UNKNOWN
Last Update Posted:
2012-10-25
First Post:
2012-10-16
Brief Title:
Efficacy of Extracorporeal Shockwave Myocardial Revascularization
Sponsor:
Salus Ltd
Organization:
Salus Ltd
Study Overview
Official Title:
Hungarian Study on the Efficacy of Extracorporeal Shockwave Myocardial Revascularization in Patients With Therapy-refracter Angina Pectoris
Status:
UNKNOWN
Status Verified Date:
2012-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ANGEL
Brief Summary:
Clinical research to justify effectiveness of the Extracorporeal Shockwave Myocardial Revascularization ESMR Therapy for treatment of patients with reversible myocardial ischemia secondary to Coronary Artery Disease CAD and therapy resistant stable angina pectoris
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None